Your email has been successfully added to our mailing list.

×
-0.000187219171243142 0.000374438342486285 0.00312031952071892 0.00312031952071892 0.00312031952071892 0.00312031952071892 0.00312031952071892 0.00312031952071892
Stock impact report

Shire rejects $63 billion Takeda bid as Allergan drops pursuit [Yahoo! Finance News]

SHIRE (SHPG) 
Last shire earnings: 11/1 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.shire.com
NEW YORK/LONDON (Reuters) - Rare disease drug maker Shire Plc said on Thursday it had rejected a $63 billion cash-and-stock acquisition offer by Japan's Takeda Pharmaceutical Co Ltd , while Allergan Plc reversed course on pursuing a rival bid. An acquisition of Shire by Takeda would be by far the biggest acquisition of a drug company year-to-date. Botox-maker Allergan confirmed on Thursday it was considering an offer for Shire after Reuters reported on its interest, sending its shares down 7 percent. Show less Read more
Impact Snapshot
Event Time:
SHPG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SHPG alerts
Opt-in for
SHPG alerts

from News Quantified
Opt-in for
SHPG alerts

from News Quantified